IDH1 Mutations in Gliomas: When an Enzyme Loses Its Grip
Research output: Contribution to journal › Article
Colleges, School and Institutes
The growing interest in cancer metabolism is best demonstrated by the rapid progress made in studying isocitrate dehydrogenase (IDH) mutations since their discovery just over a year ago. In a recent study published in Nature, Dang et al. identified 2-hydroxyglutarate as a product of tumor-associated IDH mutants with potential oncogenic activities.
|Number of pages||3|
|Publication status||Published - 1 Jan 2010|